Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression. Parkside Psychiatric Hospital has a Spravato outpatient clinic ...

Beta-blockers, such as Inderal (propranolol) and Tenormin (atenolol), are also sometimes used to treat certain types of anxiety. Beta-blockers are used off-label for anxiety. This means that the Food ...

Almost Three Quarters of Adolescents Experience Depression or Anxiety Dec. 17, 2024 — Almost three quarters of adolescents in Australia experience clinically significant depression or anxiety ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

I also offer Esketamine ( Spravato) for clients suffer from Treatment ... Whether you're struggling with anxiety, depression, trauma, self-harm, suicidal ideation, or any ongoing mental health ...

The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for refractory systemic lupus erythematosus with extrarenal involvement, marking the ...